Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Revolution Medicines Inc. Common Stock — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.98 (market cap $25.27B), while Revolution Medicines Inc. Common Stock trades at $190.57 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| RPRX | RVMD | |
|---|---|---|
Market Cap | $25.27B | $40.32B |
Volume | 3,671,183 | 4,855,734 |
Sector | Health | Health |
52-Week High | $63.96 | $221.15 |
52-Week Low | $35.44 | $47.50 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $32.50B | $37.02B |
Dividend Yield | 1.66% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
